Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


MSD wants antibiotic change

Posted 24 September 2020

MSD is calling for an increased effort to back innovative antimicrobials in response to the launch of MTPConnect's white paper 'Fighting Superbugs', which acknowledges industry as a key contributor in addressing antimicrobial resistance (AMR).

The paper recommends new reimbursement and procurement models for antimicrobials be considered in Australia, such as an alternative payment scheme and delinking payments from sales volume.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
UPDATES: UNICEF stockpiling one billion syringes
Approvals Action
Shakeup for insulin
New biosim plus hypertension and herpes generics
Top of the Hill
Avoiding the Emperor's mistake
Not everyone is convinced about industry's budget win